Natera to Report its Fourth Quarter and Full Year Results on February 27, 2025

Business Wire

02-18

AUSTIN, Texas, February 18, 2025--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will release results for its fourth quarter and year ended Dec. 31, 2024, after the market closes on Feb. 27, 2025. Natera will host a conference call and webcast shortly thereafter at 1:30 p.m. PT (4:30 p.m. ET).

Earnings Conference Call Information

Event:		Natera’s Fourth Quarter & Full Year 2024 Financial Results
Date:		February 27, 2025
Time:		1:30 p.m. PT (4:30 p.m. ET)
Live Dial-In:		1-888-770-7321 (Domestic)
		1-929-201-7101 (International)
Conference ID:		7684785
Webcast:		https://events.q4inc.com/attendee/538630796

A webcast replay will be available at investor.natera.com.

About Natera

Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are validated by more than 250 peer-reviewed publications that demonstrate high accuracy. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California. For more information, visit www.natera.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250218525659/en/

Contacts

Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-826-2350, investor@natera.com
Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., pr@natera.com

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2512175165"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2512175165\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2512175165?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-18 22:00","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2512175165","market":"us","top_or_hot":-1,"title":"Natera to Report its Fourth Quarter and Full Year Results on February 27, 2025","media":"Business Wire","content":"<html><body>\n<figure>\n<img border=\"0\" height=\"200\" src=\"https://s.yimg.com/uu/api/res/1.2/FJ2DRN0_NLIBz6VXCS8OjA--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/business-wire.com/972705011c1df2255a8b350291939eda\" title=\"\" width=\"200\"/>\n<figcaption></figcaption>\n</figure>\n<p><b>AUSTIN, Texas, February 18, 2025</b>--(BUSINESS WIRE)--<a href=\"https://laohu8.com/S/NTRA\">Natera, Inc.</a> (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will release results for its fourth quarter and year ended Dec. 31, 2024, after the market closes on Feb. 27, 2025. Natera will host a conference call and webcast shortly thereafter at 1:30 p.m. PT (4:30 p.m. ET).</p>\n<p><b>Earnings Conference Call Information</b></p>\n<table cellspacing=\"0\">\n<tbody>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"><p>Event:</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>Natera’s Fourth Quarter &amp; Full Year 2024 Financial Results</p></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"><p>Date:</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>February 27, 2025</p></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"><p>Time:</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>1:30 p.m. PT (4:30 p.m. ET)</p></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"><p>Live Dial-In:</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>1-888-770-7321 (Domestic)</p></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>1-929-201-7101 (International)</p></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"><p>Conference ID:</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>7684785</p></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"><p>Webcast:</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>https://events.q4inc.com/attendee/538630796</p></td>\n</tr>\n</tbody>\n</table>\n<p>A webcast replay will be available at investor.natera.com.</p>\n<p><b>About Natera</b></p>\n<p>Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are validated by more than 250 peer-reviewed publications that demonstrate high accuracy. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California. For more information, visit www.natera.com.</p>\n<p><span>View source version on businesswire.com: </span><span>https://www.businesswire.com/news/home/20250218525659/en/</span></p>\n<p><b>Contacts</b></p>\n<p>Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-826-2350, investor@natera.com <br/>Media: Lesley Bogdanow, <a href=\"https://laohu8.com/S/VP..UK\">VP</a> of Corporate Communications, Natera, Inc., pr@natera.com<br/></p></body></html>","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Natera to Report its Fourth Quarter and Full Year Results on February 27, 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNatera to Report its Fourth Quarter and Full Year Results on February 27, 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-18 22:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/natera-report-fourth-quarter-full-140000252.html><strong>Business Wire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AUSTIN, Texas, February 18, 2025--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will release results for its fourth ...</p>\n\n<a href=\"https://finance.yahoo.com/news/natera-report-fourth-quarter-full-140000252.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://finance.yahoo.com/news/natera-report-fourth-quarter-full-140000252.html","article_id":"2512175165","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2512175165","pubTimestamp":1739887200,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"AUSTIN, Texas, February 18, 2025----Natera, Inc. , a global leader in cell-free DNA and genetic testing, today announced that it will release results for its fourth quarter and year ended Dec. 31, 2024, after the market closes on Feb. 27, 2025. Natera will host a conference call and webcast shortly thereafter at 1:30 p.m. PT .Natera’s Fourth Quarter & Full Year 2024 Financial Results. Natera is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are validated by more than 250 peer-reviewed publications that demonstrate high accuracy. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments  in Austin, Texas, and San Carlos, California. For more i","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"Natera将于2025年2月27日公布第四季度和全年业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CLIA":1,"NTRA":1},"content_text":"AUSTIN, Texas, February 18, 2025--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will release results for its fourth quarter and year ended Dec. 31, 2024, after the market closes on Feb. 27, 2025. Natera will host a conference call and webcast shortly thereafter at 1:30 p.m. PT (4:30 p.m. ET).\nEarnings Conference Call Information\n\n\n\nEvent:\n\nNatera’s Fourth Quarter & Full Year 2024 Financial Results\n\n\nDate:\n\nFebruary 27, 2025\n\n\nTime:\n\n1:30 p.m. PT (4:30 p.m. ET)\n\n\nLive Dial-In:\n\n1-888-770-7321 (Domestic)\n\n\n\n\n1-929-201-7101 (International)\n\n\nConference ID:\n\n7684785\n\n\nWebcast:\n\nhttps://events.q4inc.com/attendee/538630796\n\n\n\nA webcast replay will be available at investor.natera.com.\nAbout Natera\nNatera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are validated by more than 250 peer-reviewed publications that demonstrate high accuracy. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California. For more information, visit www.natera.com.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20250218525659/en/\nContacts\nInvestor Relations: Mike Brophy, CFO, Natera, Inc., 510-826-2350, investor@natera.com Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., pr@natera.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1}}}